Genome scale CRISPR Cas9a knockout screen reveals genes that controls glioblastoma susceptibility to the alkylating agent temozolomide
C. U. Awah, J. Winter, O. Ogunwobi
This study uses a genome-wide CRISPR-Cas9a knockout screen to identify genes influencing glioblastoma resistance to temozolomide.
bioRxiv · Aug 11, 2021Cancer Biology